Skip to main content
logo
Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
86.74
+0.06 (0.07%)
Oct 22, 2026, 9:31 AM EDT - Market open

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States Revenue
4.81B4.67B4.56B
International Revenue
3.50B3.66B3.70B
Revenue (Other)
1.00M--
Revenue (Total)
8.31B8.33B8.25B

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
MedSurg Revenue
5.05B4.82B4.64B
Dental Solutions Revenue
1.43B1.35B1.30B
Health Information Systems Revenue
1.39B1.36B1.31B
Purification and Filtration Revenue
-497.00M709.00M
Corporate and Unallocated Revenue
437.00M302.00M306.00M
Revenue (Other)
4.00M-1.00M
Revenue (Total)
8.31B8.33B8.25B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product Revenue
6.30B6.35B6.35B
Software and Rental Revenue
2.01B1.98B1.91B
Revenue (Total)
8.31B8.33B8.25B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
MedSurg Operating Income
910.00M810.00M887.00M
Dental Solutions Operating Income
389.00M346.00M350.00M
Health Information Systems Operating Income
542.00M496.00M431.00M
Purification and Filtration Operating Income
-96.00M74.00M
Corporate Operating Income
210.00M432.00M-706.00M
Operating Income (Other)
25.00M1.00M-
Operating Income (Total)
2.08B2.18B1.04B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Organic Sales Growth
3.30%1.20%